4-Methylamino antipyrine determination in human plasma by high-performance liquid chromatography tandem mass spectrometry

Biomed Chromatogr. 2020 Oct;34(10):e4913. doi: 10.1002/bmc.4913. Epub 2020 Jun 26.

Abstract

In the present study, a simple and rapid method for metamizole metabolite 4-methylamino antipyrine (MAA) determination in human plasma was developed, validated and successfully applied to a clinical trial. Chromatographic separation was achieved in HILIC mode on a YMC-Pack SIL column (100 × 2.0 mm; S-5 μm, 30 nm), with a mobile phase consisting of acetonitrile, water and formic acid. Protein precipitation of a small plasma volume using acetonitrile was selected for sample preparation. The multiple reaction monitoring transitions in the positive ionization mode were m/z 218.2 → 56.2 for MAA and m/z 221.2 → 56.2 for MAA-d3 (IS, internal standard). Concentration levels of MAA calibration standards were in the range of 0.100-20 μg/ml. Metamizole conversion into MAA in both water and organic media was investigated, and the level of the conversion in commercially available injection solutions was estimated.

Keywords: 4-methylamino antipyrine; HPLC-MS/MS; human plasma; hydrolyzation-oxidation reaction; metamizole.

MeSH terms

  • Antipyrine / analogs & derivatives*
  • Antipyrine / blood*
  • Antipyrine / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Dipyrone / administration & dosage
  • Dipyrone / pharmacokinetics
  • Humans
  • Limit of Detection
  • Linear Models
  • Reproducibility of Results
  • Solid Phase Extraction
  • Tandem Mass Spectrometry / methods*

Substances

  • Dipyrone
  • Antipyrine